The FDA has approved obecabtagene autoleucel (Aucatzyl) to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Nurses in Northern Ireland have been offered a 5.5% pay rise for this year, although they are facing further delays in receiving their full back pay, it has been announced. Health minister Mike ...

Three Manitoba nurses were punished this year after repeatedly claiming they had no criminal records despite past impaired driving convictions, as the provincial regulator says it's working to ...

Credit: Getty Images The American College of Rheumatology has released a new guideline summary for the screening, treatment, and management of lupus nephritis. The guideline authors recommend ...

demonstrated a statistically significant and clinically meaningful improvement in progression-free survival compared with a combination of fludarabine-cyclophosphamide-rituximab or bendamustine ...

The government has planned for a pay rise of 2.8% for nurses working in general practice and the NHS for 2025/26, it has been announced. In written evidence to the pay review bodies for general ...

Health service nurses and midwives across the UK are once again being offered free taxi journeys to and from work and a free meal this Christmas. Ride-hailing and food delivery company Uber announced ...

Pola-R-CHP is a modified version of the R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) in which vincristine is replaced with polatuzumab vedotin.

Fludarabine's labeling now reflects that the chemotherapy can be used for adults with B-cell CLL in combination with cyclophosphamide and rituximab, and as monotherapy for those who have failed on ...

In total, 32 patients had a matched sibling donor, parental consent, and underwent allo-SCT with a myeloablative conditioning regimen consisting of busulfan, cyclophosphamide, and rabbit anti ...

2 in Blood. Noting that posttransplant cyclophosphamide (PtCy) has improved GvHD prophylaxis in haplo-HCT, but that patients continue to experience life-threatening complications, Ramzi Abboud ...